Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87,819,638
-
Total 13F shares
-
1,334,454
-
Share change
-
+1,334,454
-
Total reported value
-
$8,435,000
-
Price per share
-
$6.32
-
Number of holders
-
17
-
Value change
-
+$8,435,000
-
Number of buys
-
17
Institutional Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q4 2021
As of 31 Dec 2021,
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,334,454 shares.
The largest 10 holders included
Prosight Management, LP, Nantahala Capital Management, LLC, AMERICAN FINANCIAL GROUP INC, P.A.W. CAPITAL CORP, Kestra Advisory Services, LLC, TWO SIGMA INVESTMENTS, LP, TWO SIGMA ADVISERS, LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and B. Riley Financial, Inc..
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.